TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Intake Breathing received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky. The family-run nasal-device company says it plans to use the funding to expand into physical retail and specialty channels and make key hires; the terms and timing of those plans were not reported.
Intake Breathing has received $62 million from Camino Partners, the investment firm founded by Kind Snacks creator Daniel Lubetzky, as the family-run company prepares to expand sales beyond its direct-to-consumer business. Intake makes a reusable magnetic nasal dilator, and the investment gives it capital and a consumer-brand investment partner as it seeks wider retail distribution.
The company says it will use the funding to pursue physical retail and specialty channels and make key hires to support growth. It has mainly sold directly to consumers so far. The source report does not specify which retailers it is targeting, when products may appear in stores, or how the investment will be allocated between distribution, staffing and other needs.
Intake was founded by Jim Castillo, an inventor and medical-device engineer, and is led by his son-in-law, co-founder and CEO Alex Hauck. Its device combines a reusable magnetic band with adhesive tabs. The company describes the product as mechanically opening the nasal valve, the narrowest part of the nasal airway. It differs from conventional adhesive strips in its reusable magnetic design.
Intake’s customer base includes professional athletes, among them Los Angeles Dodgers pitcher Justin Wrobleski and Belgian soccer player Amadou Onana, according to the report. That visibility offers the brand a route to sports and fitness consumers, though the investment announcement does not establish how widely the product is used or demonstrate a particular health or performance outcome.
Retail Expansion After Direct Sales
The investment could give Intake resources to move from a primarily direct-to-consumer model into stores and specialist outlets, where shoppers can encounter the product alongside other health, fitness and wellness goods. Physical distribution can broaden a consumer brand’s reach, but the announcement does not confirm retail agreements or forecast sales, so the scale and speed of any expansion remain unknown.
For Camino, the deal is a bet that nasal-breathing products can reach a larger consumer market. Lubetzky compared the opportunity with the early growth of Kind, while Camino president Elle Lanning said the firm sees potential to make nasal strips a more regular part of wellness routines. Those are investor expectations, not established market results. The funding marks a major new source of capital for Intake, but whether it builds sustained demand will depend on execution and consumer response.
Products Worth Considering
Oura Ring 4 Smart Ring – Silver – Size 8
BowFlex Results Series SelectTech 552 Adjustable Dumbbell
Bowflex SelectTech 840 Adjustable Kettlebell
As an affiliate, we earn on qualifying purchases.
A Magnetic Alternative to Adhesive Strips
Intake’s product is designed to support airflow through the nose by opening the nasal valve with an external magnetic system. Traditional nasal strips use adhesive material placed across the nose; Intake instead pairs a reusable band with adhesive tabs. The company presents this as a distinct product design, but the source report provides no clinical evidence or head-to-head testing establishing comparative effectiveness.
The company has grown as consumer interest in sleep, recovery and performance has drawn attention to breathing-related products. Intake’s athlete users are part of that public profile. Camino’s portfolio also includes boutique fitness company Barry’s and nonalcoholic beer maker Athletic Brewing, placing the investment within the firm’s wider focus on consumer brands linked to health and wellness.
“We’re not just gaining capital, we’re gaining a partner who knows exactly what it takes to help get us there.”
— Alex Hauck, Intake co-founder and CEO
Retail Plans and Deal Terms
The source report does not disclose the investment’s structure, Camino’s ownership stake, or whether other investors participated. It also gives no timetable for retail launches, names no retail partners, and does not detail the planned hires or expected spending. Intake’s future distribution and the results of its expansion are therefore still undetermined.
The announcement describes how the device is designed, but does not provide independent testing or clinical findings on its effects. Claims about breathing, sleep, recovery or athletic performance should not be treated as proven outcomes on the basis of the funding news. The report also does not state whether the company will pursue any regulatory or product-label changes as it broadens distribution.
Hiring and Distribution Milestones
The next visible steps will be whether Intake announces retail or specialty-channel partners, begins hiring for its expansion, and provides a clearer rollout schedule. Those developments would show how the company plans to turn the new funding into wider availability. Until then, the confirmed plan is limited to pursuing those channels and making key hires.
Further information from Intake or Camino may clarify the investment terms, spending priorities and timing. The source report does not identify a specific next announcement or milestone, so there is no confirmed date for additional details.
Key Questions
Who invested $62 million in Intake Breathing?
Camino Partners, the investment firm founded by Daniel Lubetzky, made the investment, according to the source report.
What does Intake Breathing make?
Intake makes a magnetic nasal dilator that uses a reusable band and adhesive tabs. The company says the device is designed to open the nasal valve.
How will Intake use the investment?
The company says it plans to expand into physical retail and specialty channels and make key hires. It has not publicly detailed the spending breakdown or rollout schedule in the source report.
Does the investment prove the product improves breathing or performance?
No. The funding announcement and product description do not establish clinical or performance outcomes. The source report provides no independent testing comparing Intake’s device with other products.
Source: athletechnews.com
